Identifying Blood Markers for Colon Cancer
Author Information
Author(s): Ward D G, Suggett N, Cheng Y, Wei W, Johnson H, Billingham L J, Ismail T, Wakelam M J O, Johnson P J, Martin A
Primary Institution: CR-UK Institute for Cancer Studies, University of Birmingham
Hypothesis
Can serum proteomics identify biomarkers for early detection of colorectal cancer?
Conclusion
The study identified proteins in the serum of colorectal cancer patients that could serve as potential biomarkers for early detection.
Supporting Evidence
- Proteins identified included complement C3a des-arg, α1-antitrypsin, and transferrin.
- Artificial neural networks achieved 95% sensitivity and 91% specificity in classifying patients.
- Current blood tests for colorectal cancer lack sufficient sensitivity and specificity.
Takeaway
Researchers found specific proteins in the blood of colon cancer patients that could help doctors detect the disease earlier.
Methodology
The study used surface-enhanced laser desorption/ionization mass spectrometry to analyze serum samples from colorectal cancer patients and noncancer subjects.
Potential Biases
Potential bias in sample collection protocols and data analysis methods.
Limitations
The study's findings need validation with larger patient groups.
Participant Demographics
62 colorectal cancer patients (35 male, 27 female) and 31 noncancer subjects (13 male, 18 female), aged 62.9±10.3 years for noncancer and 67.3±12.9 years for CRC.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website